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Abstract 
AIM: This study was designed to compare the safety and feasibility of uterine fibroid embolisation (UFE) via 
transradial access (TRA) and transfemoral access (TFA). 
MATERIAL AND METHODS: A retrospective analysis was conducted for 2 cohorts: 13 cases with already 
established TFA (from February 2016 to September 2018) and the first 11 procedures performed via TRA (from 
October 2017 to October 2018). Indications for embolization included: heavy menstrual bleedings (n = 18), lower 
urinary tract symptoms (n = 2), pelvic pain (n = 3) and abdominal pain (n = 1). One interventional radiologist and 
one fellow performed all procedures at one institution. Technical success, procedural time, access site 
complications as well as feedback from patients were assessed for analysis. 
RESULTS: Technical success was achieved in 24/24 cases (100%). Unilateral uterine artery embolisation was 
performed in 7 cases (29.1%) and bilateral in 17 cases (70.8%). Mean procedure time was 72.4 minutes in TFA 
group, and 60.3 minutes in the TRA group. Mean fluoroscopy time was 25.3 minutes in the TFA group and 21.1 
minutes in the TRA group. Access site-related and overall adverse events did not vary significantly among the 
study cohorts. 
CONCLUSIONS: TRA represents a safe and feasible approach for UFE with a comparable safety profile to TFA. 
 
 
 
 
 
 
 
Introduction 
 
Uterine fibroids are the most common 
gynaecological benign tumours in women and can 
cause symptoms like severe menstrual bleedings with 
or without repercussion of blood account, pelvic or 
abdominal pain, swelling, urinary tract symptoms, 
bowel compression etc. Uterine fibroid embolisation 
(UFE) is a minimally invasive endovascular procedure 
which is performed for the treatment of fibroids. On 
the other hand, surgery is the standard treatment of 
choice for this pathology offered by gynaecologists. 
Hysterectomy and myomectomy, both in the classical 
or laparoscopic way are the most common surgical 
techniques. UFE is an established endovascular 
interventional technique which includes delivery of 
embolic agents through the uterine arteries directly in 
uterus and fibroids. This intervention is typically 
offered to women who refuse surgery. 
Further it is commonly practiced in women 
who want to preserve their uterus by any means, who 
are contraindicated to surgery due to comorbidities, 
younger women etc. Traditionally, transfemoral 
access (TFА) has been the standard approach for 
performing this intervention as well as for other 
procedures in interventional radiology (IR), proven in a 
number of studies so far. Transradial access (TRА) is 
a relatively new approach in interventional radiology 
(IR) and so far has been used predominantly in 
interventional cardiology for the past few decades. 
Due to improved patient comfort, minor access site 
complications, earlier ambulation and reduced costs, 
TRA is becoming more popular also in some IR 
procedures such as: visceral embolizations with 
predominance of transarterial chemoembolization 
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(TACE) and radioembolization (TARE), embolization 
of gastrointestinal bleedings, carotid artery stenting 
and lately in some centers also for UFE. Reviewing 
the literature on this particular topic, there are not 
many papers connecting TRA and UFE. Those few 
small series published speak for its safety and good 
feedback from patients. In our hospital, UFE has been 
practiced from 2015, and from the end of 2017 we 
started using TRA for this procedure.  
In this article, we present our initial 
experience using TRA for UFE compared to that of 
TFA regarding the safety profile and the procedural 
eligibility. 
 
 
Material and Methods 
 
Institutional review board approval was 
obtained for this retrospective study. Retrospective 
analysis was conducted for twenty-four women with 
UFE with 29 fibroids in the period from February 2016 
to October 2018, reviewing our hospital information 
system. Thirteen women with TFA and eleven with 
TRA embolisation of uterine fibroid mean age 39 y. 
(range 29-47 y.) were analysed. Twenty-one of them 
(87.5%) have already completed reproduction, with at 
least one childbirth, with no particular desire for further 
reproduction. Two of them (8.3%) have no children (in 
these two myomas/fibroids were considered as one of 
the possible causes of infertility). One woman (4.1%) 
with one child, with a desire for another conception in 
future. All patients were symptomatic and indications 
for embolization included: heavy menstrual bleedings 
(n = 18) 75%, lower urinary tract symptoms (n = 2) 
8.3%, pelvic pain (n = 3) 12.5% and abdominal pain (n 
= 1) 4.1%. Demographic patient characteristics 
between the two groups did not differ significantly 
(Table 1). Patients were divided into 2 groups: 13 
cases with already established TFA (from February 
2016 to September 2018) and the first 11 procedures 
performed via TRA (from October 2017 to October 
2018). All procedures were performed by one 
interventional radiologist with experience of more than 
400 visceral embolisations and one fellow in 
Radiology. 
Table 1: Patient and procedural characteristics 
 TFA group TRA group 
Number of women  
13 
 
11 
 
Median age 
 
31-45 
 
 
29-47 
 
Number of fibroids 16 13 
Completed reproduction 10 11 
Technical success 100% 100% 
Total procedure 
time(minutes) 
72.4 60.3 
Fluoroscopy time(minutes) 25.3 21.1 
Hospital days per 
procedure 
2 0 
Minor complications 1 0 
Clinical symptoms 
improvement 
13 9 
In the TFA group, standard Seldinger 
technique was used with 5F introducer in the right 
common femoral artery (CFA). 5F Cobra 2 catheter 
was used for catheterisation of left internal iliac artery 
and Simmons 2 catheter for right internal iliac artery. 
In all femoral cases, 2,7F 130cm long microcatheter 
(Program, Terumo, Japan) was used for 
superselective catheterisation of uterine arteries and 
consequent embolisation. 
 
Figure 1: Pelvic MRI; T1 FS contrast-enhanced axial MRI of uterus 
pre embolisation shows 2 large intramural hypervascular fibroids 
(arrow) in the left side of uterus body with a displacement of cavum 
uteri 
In the TRA group, the preprocedural US of the 
radial artery was performed together with Barbeau 
test for depicting patency of hand vessels. Radial 
arteries smaller than 2.5 mm in diameter were 
considered as too small for puncture, and these 
patients were excluded from radial puncture and 
converted to femoral access. Micropuncture set for 
transradial access (5F Slender Glidesheath, Terumo, 
Japan) was used in all radial cases with 110 cm MP or 
125 angled catheter for cannulation of hypogastric 
artery.  
 
Figure 2: Left transradial access with the insertion of 5F 
Glidesheath, Slender, Terumo 
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One 150 cm long 2.8F microcatheter 
(Program, Terumo, Japan) in combination with GT 
microwire was chosen for uterine artery super 
selective catheterisation. Left radial artery was used 
for all of the eleven TRA cases. 
 
Figure 3: Digital subtraction angiography of pelvic arteries showed 
large and hypertrophied left uterine artery predominantly supplying 
the fibroids 
 
Embolisation was performed by using PVA or 
PEG particles with size from 500-1000 microns. Type 
and size of particles were selected as per every case 
on the discretion of the operator.  
 
Figure 4: Angiographic findings pre and post-embolization; A) 
Transradial super selective angiography of left uterine artery pre 
embolization with 2.8F 150 cm long microcatheter shows large 
hypervascular fibroid; B) Postembolization angiography in the same 
patient shows complete embolization of left uterine artery with PVA 
particles and stasis of contrast at the tip of microcatheter while mail 
uterine artery is still patent 
 
Haemostasis of the femoral artery was 
achieved with manual compression, and haemostasis 
of the radial artery was done with TR Band (Terumo 
Interventional Systems) in all cases. 
Pelvic contrast-enhanced MRI and complete 
blood account tests were assessed before 
intervention in every case. The degree of achieved 
necrosis of the fibroids was assessed by control pelvic 
enhanced MRI 1-2 months after embolisation.  
  
Conversation with the interventional 
radiologist about improving symptoms and quality of 
life, complete blood tests and radial artery ultrasound 
was also part of the postprocedural follow up at 1 
month interval. 
 
Figure 5: One and a half month post embolisation T1 FS contrast-
enhanced axial MRI of the uterus in the same patient shows 
complete necrosis of both fibroids (arrow) and preservation of 
uterine body wall with normal enhancement 
 
 
  
Results 
 
Technical success of the procedure was 
achieved in 24/24 cases (100%). Unilateral uterine 
artery embolisation was performed in 7 cases (29.1%) 
and bilateral in 17 cases (70.8%). The decision for 
unilateral UFE was made by carefully reviewing of the 
preprocedural US and MRI, and in all these cases 
fibroids were predominantly vascularized by one 
uterine artery (> 80%). Mean procedural time was 
72.4 minutes in TFA group, and 60.3 minutes in the 
TRA group. Mean fluoroscopy time was 25.3 minutes 
in the TFA group and 21.1 minutes in the TRA group. 
Access site-related and overall adverse events did not 
vary significantly among the study cohorts. One non-
flow-limiting dissection of left internal iliac artery 
occurred in the TFA group during manipulation with 
hydrophilic wire which resolved spontaneously at the 
end of the procedure. In one patient in the TRA group, 
there was prolonged pain in the left forearm for 14 
days which was managed conservatively with use of 
non-steroidal anti-inflammatory drugs. 
Patients in the TRA group left the hospital the 
same day 3-4 hours after the procedure with a 
bandage at the left radial artery. In the TFA group 
patients stayed in the hospital for two nights, one day 
prior and one day after the procedure. There were no 
late major complications in both groups. In all TRA 
cases, radial artery remained patent without signs of 
thrombosis, which was confirmed with the US on one-
month control examination.  
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Discussion 
 
Transfemoral approach for uterine artery 
embolisation is an established technique for the 
treatment of uterine fibroids. Different catheters and 
manoeuvres have been described in the literature for 
cannulation of uterine arteries via transfemoral 
access. In recent years, transradial approach is 
gaining more and more popularity in the IR 
community, especially for some visceral artery 
interventions. It’s proven safety and benefits in 
interventional cardiology interventions by a number of 
studies was followed by some small series in 
interventional radiology as well. 
In this retrospective review of procedural 
safety and efficacy in a small cohort of patients 
treated with transradial approach, we did not observe 
any major complications during or after the procedure. 
Fluoroscopy time was less than that in TFA group 
without any statistical significance and we found that 
cannulation of the uterine artery is almost always 
easier when we used TRA. Main advantage so far is 
that the procedure can be performed as an outpatient 
one without patient hospitalisation. This was proven to 
be of great importance for patients when we were 
doing the postprocedural questionary. According to 
the results from this study, we can clearly say that 
TRA is a safe and effective alternative to TFA for UFE 
in carefully selected patients. 
Evеry woman with the radial artery of 3 mm or 
greater diameter is a candidate for transradial UFE. 
Compared to TFA, there is shorter hospital stay and 
reduced total costs in the TRA procedure. 
Limitations of the study: This is a small, 
retrospective study for gaining large and long-term 
conclusions. Also, it is a single centre so we cannot 
compare or share the results from other centres as 
well. 
In conclusion, we think that TRA is potentially 
safe end effective approach for uterine fibroid 
embolisation. According to our experience so far it 
appears to be a highly promising treatment option for 
a woman with symptomatic fibroids. The main 
advantage of this procedure is early verticalization of 
the patients and same day discharge from the 
hospital. 
Potential limitations so far are the lack of 
adequate materials (catheters and microcatheters) 
that can easily reach the ostium of every uterine artery 
via radial access. Also, the diameter of radial artery 
and total body height of the patient is a very important 
prognostic factor that can influence the success of the 
procedure. 
Further studies with larger numbers of 
patients with follow-ups on longer intervals are 
necessary to assess the effectivness of TRA for 
uterine fibroid embolization better.  
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